Friday 19 January 2018 ShareProphets: The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

Concepta Interims - barely relevant but catch the Reynolds Q&A! Buy

By HotStockRockets | Saturday 20 August 2016

Disclosure: Financial Investigative Media Limited, which is not owned by Tom Winnifrith but by a trust for his dependants, owns shares in companies mentioned in this article. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Concepta (CPT) the latest Adam Reynolds healthcare RTO on AIM has announced interim result which are pretty academic. The company is a developer of a platform and suite of products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility.

During the half calendar year the old oil & gas operations of Frontier Resources (FRI) were binned and Concepta was bought for £3.026 million comprising 30,343,950 New Ordinary Shares and £0.75 million in cash. that deal took place in July 2016.

The cash position at the period end was $1.335 million and the cashburn from continuing operations was $336,000 which implies that the company could keep going for two years without any sales. But sales are coming and are coming soon.

Concepta says that regulatory approvals for launch in China in are place with a first order from a distributor with payment in advance expected following hospital testing in Q3 2016. In 2017 we will see CE-Marking for UK and Europe and then sales. The market being targeted is worth c£600 million so even a small market share will see this one race ahead.

How soon will that happen...well have a read of an interview with Adam Reynolds out today HERE

At 13p the shares are a buy at up to 16p - the target to sell is 25p well before Christmas.

To catch the next share tip from HotStockRockets out next week for just £5 click HERE

Filed under:

Never miss a story.

This area of the site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.

More on CPT


Comments are turned off for this article.

Site by Everywhen